Zoom Support Group Meeting – Vicore Study Earn $250.00

  • By Terri Pilawa

Please join us for our Support Group Zoom Meeting

Date: Sunday, December 4, 2022

Time: 1:00 pm PDT

Round Table with Terri Pilawa

Topic: New Clinical Trials and Studys get involved

First study to use digital therapeutics on 
pulmonary fibrosis (PF) begins national patient enrollment

PF patients who enroll and participate in the study may earn $250.00

CHICAGO, November 29, 2022 — A first-of-its-kind digital therapeutics research study may offer new hope for patients with a rare lung disease and are having difficulty with anxiety. Vicore Pharma recently launched the study across the U.S. Vicore Pharma AB is a clinical-stage pharmaceutical company focused on developing innovative medicines in severe lung diseases.


Here’s another IPF research study

We can help advance IPF research for our patient community. Those who have been diagnosed with pulmonary fibrosis and are 40 years or older can determine their eligibility for a clinical trial here: lpcu.re/OneBreath 


Here’s another Study not only for lung but other organs and diseases. 





Join Zoom Meeting
Meeting ID: 894 7558 4478
Passcode: OneBreath

See you there!